Sonoma Pharmaceuticals Announces Asset Purchase Agreement with Middle East Partner MicroSafe Group Feb 27, 2020
Sonoma Pharmaceuticals Engages Maxim Group LLC to Explore Strategic Opportunities for its U.S. Dermatology Division Jan 23, 2020
Sonoma Pharmaceuticals Announces Closing of $1.6 Million Public Offering of Common Stock Nov 29, 2019
Sonoma Pharmaceuticals Announces Pricing of Approximately $1.6 million Public Offering of Common Stock Nov 26, 2019
